Infrarenal Abdominal Aortic Aneurysm
Conditions
Interventions
Control:Medtronic Endurant stent graft
Experimental group:MicroPort Minos stent graft
Sponsors
Zhongshan Hospital Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Males or non-pregnant females aged >=18 years; 2. Definitive diagnosed with infrarenal abdominal aortic aneurysm 3. The length of the aneurysm neck >=15mm, and the angle between the neck and the aneurysm <=60 degree; 4. Suitable candidates for surgical treatment; 5. Available iliac and femoral artery access; 6. Suitable for endovascular treatment according to the researcher's judgment; 7. Patients who can understand the purpose of the trial, volunteer to participate and sign informed consent forms, and are willing to follow up.
Exclusion criteria
Exclusion criteria: 1. Landing zone with severe stenosis or calcification, which is difficult to adhere to; 2. Patients with ruptured aneurysm or acute aneurysm; 3. Patients with infectious aneurysm; 4. Diagnosed with suprarenal aneurysm and pararenal aneurysm; 5. Patients without at least one internal iliac artery; 6. History of myocardial infarction or unstable angina pectoris in the past 3 months; 7. History of TIA or cerebral infarction in the past 3 months; 8. Allergic to contrast media, Nitinol and other stent materials; 9. Patients with connective tissue diseases, such as Marfan syndrome; 10. Patients whose creatinine exceeds 2.5 times the upper limit of normal or who are on dialysis; 11. Patients with severe disease such as liver failure; 12. Life expectancy < 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Freedom from MAE at 30 days;12-month clinical success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Second intervention;All cause death;Aneurysm related death;Serious adverse event;Device-related adverse events; | — |
Countries
China
Contacts
Public ContactWeiguo Fu
Zhongshan Hospital Fudan University
Outcome results
None listed